Friday, September 13, 2019

Few people with peanut allergy tolerate peanut after stopping oral immunotherapy

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

09/13/2019 09:15 AM EDT

Continuing with a modest dose confers more protection, NIH-funded study finds.

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

No comments:

Post a Comment